Sec. 1004. Inclusion of pregnant individuals and lactating individuals in vaccine and therapeutic development for COVID–19
80 words·~1 min read·
/bill/117/s/346/is/section-1004·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Director of the National Institutes of Health shall, when safe and appropriate, support and advance the inclusion of pregnant and lactating individuals in therapeutic and vaccine clinical trials with respect to the treatment or prevention of COVID–19, including prioritizing recommendations made by the Task Force on Research Specific to Pregnant Women and Lactating Women established under section 2041 of the 21st Century Cures Act ( 42 U.S.C. 289a–2 note) with respect to including such individuals in such clinical trials.
Connections1 off-index
1 reference not yet in our index
- 42 USC 289a–2
Citation graph
cites case law
Sec. 1004
Inclusion of pregnant individuals and lactating individuals in vaccine and therapeutic development for COVID–19
Cite42 USC 289a–2
Cites 1Cited by 0 across 0 sources